Publicacions dels grups de recerca: Gener 2013
Tecnologies sanitàries i resultats en Atenció Primària 5/7; FI= 10,893
Bendeck M, Serrano-Blanco A, García-Alonso C, Bonet P, Jordà E, Sabes-Figuera R, Salvador-Carulla L. An integrative cross-design synthesis approach to estimate the cost of illness: An applied case to the cost of depression in Catalonia.. J Ment Health 2013 :in print
Cebolla A, Luciano JV, Demarzo MP, Navarro-Gil M, Campayo JG. Psychometric properties of the Spanish version of the mindful attention awareness scale (MAAS) in patients with fibromyalgia.. Health Qual Life Outcomes 2013 :in print Factor d'impacte: 2,112 Quartil: Q2
López-Del-Hoyo Y, Olivan B, Luciano-Devis JV, Mayoral F, Roca M, Gili M, Andres E, Serrano-Blanco A, Collazo F, Araya S, Baños R, Botella C, Magallón R, Campayo JG. Low intensity vs. self-guided Internet-delivered psychotherapy for major depression: a multicenter, controlled, randomized study.. BMC Psychiatry 2013 :in print Factor d'impacte: 2,552 Quartil: Q2
Luciano JV, Sabes-Figuera R, Cardeñosa E, Peñarrubia-María M, Fernández-Vergel R, García-Campayo J, Knapp M, Serrano-Blanco A. Cost-Utility of a Psychoeducational Intervention in Fibromyalgia Patients Compared With Usual Care: An Economic Evaluation Alongside a 12-Month Randomized Controlled Trial.. Clin J Pain 2013 :in print Factor d'impacte: 2,813 Quartil: Q2
McCrone P, Singh SP, Knapp M, Smith J, Clark M, Shiers D, Tiffin PA. The economic impact of early intervention in psychosis services for children and adolescents.. Early Interv Psychiatry 2013 :in print Factor d'impacte: 0,920 Quartil: Q4
Sabes-Figuera R, McCrone P, Kendricks A. Refining cost-effectiveness analyses using the net benefit approach and econometric methods: An example from a trial of anti-depressant treatment.. J Ment Health 2013 :in print
Whitaker R, Ballard C, Stafford J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Knapp M, Carlton BW, Fossey J. Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trial.. Trials 2013 :in print Factor d'impacte: 2,496 Quartil: Q2
Malalties infeccioses i immunopatologia infantil 7/9; FI= 21,146
Alvaro M, Sancha J, Larramona H, Lucas JM, Mesa M, Tabar Al, Martinez-Cañavate A, Immunotherapy Working Group; Sociedad Española de Inmunología Clínica y Alergia Pediátrica (SEICAP) Allergen-specific immunotherapy: Update on immunological mechanisms.. Allergol Immunopathol (Madr) 2013 :in print Factor d'impacte: 1,043 Quartil: Q4
Baquero-Artigao F, Del Castillo Martín F, Fuentes Corripio I, Goncé Mellgren A, Fortuny-Guasch C, De la Calle Fernández-Miranda M, González-Tomé MI, Couceiro Gianzo JA, Neth O, Ramos Amador JT, Grupo de Trabajo de Infección Congénita y Perinatal de la Sociedad Española de Infectología Pediátrica (SEIP) Guía de la Sociedad Española de Infectología Pediátrica para el diagnóstico y tratamiento de la toxoplasmosis congénita. An Pediatr (Barc) 2013 :in print (VIH) Factor d'impacte: 0,770 Quartil: Q4
Ciruela P, Martínez A, Izquierdo C, Hernández S, Broner S, Muñoz-Almagro C, Domínguez A, Of Catalonia Study Group TM. Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.. Hum Vaccin Immunother. 2013 :in print (Vigilància epidemiològica molecular de les malalties prevenibles amb vacunes)
De Jose MI, Jiménez de Ory S, Espiau M, Fortuny C, Navarro ML, Soler-Palacín P, Muñoz-Fernandez MA, from the working groups of CoRISpe and HIV HGM BioBank. A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe).. BMC Infect Dis. 2013 :in print (VIH) Factor d'impacte: 3,118 Quartil: Q2
Hernández-Bou S, Novell CB, Alins JG, García-García JJ, the Infectious Diseases Working Group, Spanish Society of Pediatric Emergencies. Hospitalized Children With Influenza A H1N1 (2009) Infection: A Spanish Multicenter Study.. Pediatr Emerg Care 2013 ;29 (1) :49-52 Factor d'impacte: 0,782 Quartil: Q3
Navallas M, Rebollo Polo M, Riaza L, Muchart López J, Maristany T. Magnetic resonance imaging in juvenile idiopathic arthritis: Peculiarities of imaging children.. Radiologia 2013 :in print
The Pursuing Later Treatment Option II (PLATO II) Project Team of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE). COHERE. Predictors of CD4+ T-Cell Counts of HIV Type 1-Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug Classes.. J Infect Dis 2013 :in print (VIH) Factor d'impacte: 6,410 Quartil: Q1
Vázquez-Ortiz M, Alvaro-Lozano M, Alsina L, García-Paba MB, Piquer-Gibert M, Giner-Muñoz MT, Lozano J, Domínguez-Sánchez O, Jiménez R, Días M, Martin-Mateos MA, Plaza-Martín AM. Safety and predictors of adverse events during oral immunotherapy for milk allergy: severity of reaction at oral challenge, specific IgE and prick test.. Clin Exp Allergy 2013 ;43 (1) :92-102 (Resposta inflamatòria sistèmica en pediatria) Factor d'impacte: 5,032 Quartil: Q1
Vicente A, Pau-Charles I, González-Enseñat MA, Muñoz-Almagro C, Cañadas MP, Noguera-Julian A, Fortuny C. High-risk alpha-human papillomavirus types: Detection in HIV-infected children with acquired epidermodysplasia verruciformis.. J Am Acad Dermatol 2013 ;68 (2) :343-5 (Vigilància epidemiològica molecular de les malalties prevenibles amb vacunes) Factor d'impacte: 3,991 Quartil: Q1
Malalties de l'adult amb origen fetal o en els primers anys de vida 3/3; FI: 11,836
Iglesias-Platas I, Court F, Camprubi C, Sparago A, Guillaumet-Adkins A, Martin-Trujillo A, Riccio A, Moore GE, Monk D. Imprinting at the PLAGL1 domain is contained within a 70-kb CTCF/cohesin-mediated non-allelic chromatin loop.. Nucleic Acids Res 2013 :in print (Estats fisiològics i patològics en el nadó) Factor d'impacte: 8,026 Quartil: Q1
Peña NV, Torres M, Cardona JA, Iniesta R. Impact of Telemedicine Assessment on Glycemic Variability in Children with Type 1 Diabetes Mellitus.. Diabetes Technol Ther 2013 :in print (Diabetis infantil) Factor d'impacte: 1,931 Quartil: Q3
Rodriguez-Guerineau L, Salvia-Roigés MD, León-Lozano M, Rodríguez-Miguélez JM, Figueras-Aloy J. Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates.. Eur J Pediatr 2013 :in print (Estats fisiològics i patològics en el nadó) Factor d'impacte: 1,879
Etiopatogènia i tractament dels trastorns mentals greus 1/1; FI= 2,156
Navinés R, Gutierrez F, Arranz B, Moreno-España J, Luisa Ímaz M, Soler V, Vázquez M, Carlos Pascual J, Martín-Santos R, Kahn DA. Long-Term and Bizarre Self-Injurious Behavior: An Approach to Underlying Psychological Mechanisms and Management.. J Psychiatr Pract. 2013 ;19 (1) :65-71 (Intervencions en salut mental) Factor d'impacte: 2,156 Quartil: Q3
Malalties neurològiques minoritàries de base genètica en l'àmbit pediàtric 4/4; FI= 17,166
Jimenez E, Garcia-Cazorla A, Colomer J, Nascimento A, Iriondo M, Campistol J. Hipotonía en el período neonatal: 12 años de experiencia. Rev Neurol 2013 ;56 (2) :72-8 (SNC) Factor d'impacte: 0,652 Quartil: Q4
Martínez-Montero P, Muñoz-Calero M, Vallespín E, Campistol J, Martorell L, Ruiz-Falcó M, Santana A, Pons R, Dinopoulos A, Sierra C, Nevado J, Molano J. Plp1 Gene Analysis In Eighty Eight Patients With Leukodystrophy.. Clin Genet 2013 :in print (Altres trastorns neurològics) Factor d'impacte: 3,128 Quartil: Q2
Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, Vanier MT, Pineda M. Disease and patient characteristics in NP-C patients: findings from an international disease registry.. Orphanet J Rare Dis 2013 :in print (Metabolisme energètic mitocondrial i atàxies) Factor d'impacte: 5,074 Quartil: Q1
Rudnik-Schöneborn S, Senderek J, Jen JC, Houge G, Seeman P, Puchmajerová A, Graul-Neumann L, Seidel U, Korinthenberg R, Kirschner J, Seeger J, Ryan MM, Muntoni F, Steilin M, Sztriha L, Colomer J, Hübner C, Brockmann K, Van Maldergem L, Schiff M, Holzinger A, Barth P, Reardon W, Yourshaw M, Nelson SF, Eggermann T, Zerres K. Pontocerebellar hypoplasia type 1: Clinical spectrum and relevance of EXOSC3 mutations.. Neurology 2013 :in print (Distrofies muscular congènites) Factor d'impacte: 8,312 Quartil: Q1